Nuvasive Stock Profit Margin
NUVADelisted Stock | USD 39.75 0.00 0.00% |
NuVasive fundamentals help investors to digest information that contributes to NuVasive's financial success or failures. It also enables traders to predict the movement of NuVasive Stock. The fundamental analysis module provides a way to measure NuVasive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NuVasive stock.
NuVasive |
NuVasive Profit Margin Analysis
NuVasive's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current NuVasive Profit Margin | 0.02 % |
Most of NuVasive's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuVasive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, NuVasive has a Profit Margin of 0.0232%. This is 100.21% lower than that of the Health Care Equipment & Supplies sector and 100.42% lower than that of the Health Care industry. The profit margin for all United States stocks is 101.83% lower than that of the firm.
NuVasive Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuVasive's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NuVasive could also be used in its relative valuation, which is a method of valuing NuVasive by comparing valuation metrics of similar companies.NuVasive is currently under evaluation in profit margin category among related companies.
NuVasive Fundamentals
Return On Equity | 0.0331 | |||
Return On Asset | 0.0242 | |||
Profit Margin | 0.02 % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 2.91 B | |||
Shares Outstanding | 52.45 M | |||
Shares Owned By Insiders | 0.27 % | |||
Shares Owned By Institutions | 99.73 % | |||
Number Of Shares Shorted | 5.76 M | |||
Price To Earning | 51.79 X | |||
Price To Book | 2.62 X | |||
Price To Sales | 1.79 X | |||
Revenue | 1.2 B | |||
Gross Profit | 865.43 M | |||
EBITDA | 211.8 M | |||
Net Income | 40.41 M | |||
Cash And Equivalents | 225.98 M | |||
Cash Per Share | 4.34 X | |||
Total Debt | 1.01 B | |||
Debt To Equity | 1.22 % | |||
Current Ratio | 1.17 X | |||
Book Value Per Share | 17.02 X | |||
Cash Flow From Operations | 169.12 M | |||
Short Ratio | 10.29 X | |||
Earnings Per Share | 0.53 X | |||
Price To Earnings To Growth | 4.83 X | |||
Target Price | 44.0 | |||
Number Of Employees | 3 K | |||
Beta | 1.07 | |||
Market Capitalization | 2.08 B | |||
Total Asset | 2.22 B | |||
Retained Earnings | 86.11 M | |||
Working Capital | 149.16 M | |||
Current Asset | 702.83 M | |||
Current Liabilities | 99.62 M | |||
Z Score | 2.23 | |||
Net Asset | 2.22 B |
About NuVasive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuVasive's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuVasive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuVasive based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NuVasive in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NuVasive's short interest history, or implied volatility extrapolated from NuVasive options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |